J. Lloyd Breedlove
Keine laufenden Positionen mehr
Profil
J.
Lloyd Breedlove served as President & Chief Executive Officer at Imalux Corp., Anpath Group, Inc., Catheter Research, Inc., and Kivalo, Inc. He also worked as a Sales Director at Mallinckrodt, Inc.(Old) and as a Director at Envirosystems, Inc. Prior to that, he was Group President & Executive Vice President at STERIS Corp.
Mr. Breedlove holds an MBA degree from Western Carolina University.
Ehemalige bekannte Positionen von J. Lloyd Breedlove
Unternehmen | Position | Ende |
---|---|---|
Anpath Group, Inc.
Anpath Group, Inc. Financial ConglomeratesFinance Anpath Group, Inc. is a holding company, through its wholly-owned subsidiary EnviroSystems, Inc., produces disinfecting, biocidal, sanitizing, and cleaning products designed to help prevent the spread of infectious microorganisms and control the growth of these disease-causing microbes, while minimizing the harmful effects to people, animals, surfaces and the environment. The company was founded on August 26, 2004 and is headquartered in Austin, TX. | Vorstandsvorsitzender | 29.05.2015 |
Imalux Corp.
Imalux Corp. Medical SpecialtiesHealth Technology Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease. Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies. In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology. | Vorstandsvorsitzender | 01.01.2006 |
Kivalo, Inc. | Vorstandsvorsitzender | 01.05.2003 |
STERIS CORP | Präsident | 01.01.1999 |
Catheter Research, Inc.
Catheter Research, Inc. Medical SpecialtiesHealth Technology Catheter Research, Inc. manufactures interventional catheters, tube sets and other assemblies for medical devices. The company was founded on September 16, 1987 and is headquartered in Indianapolis, IN. | Vorstandsvorsitzender | 01.01.1991 |
Ausbildung von J. Lloyd Breedlove
Western Carolina University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Mallinckrodt, Inc.(Old)
Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | Health Technology |
STERIS Corp.
STERIS Corp. Medical SpecialtiesHealth Technology STERIS Corp. provides infection prevention and other procedural products and services. Its product and services offers hospitals and surgery centers, medical device, pharmaceutical and biotechnology manufacturers, and research laboratory. The company was founded by Michael A. Keresman III, Raymond C. Kralovic and Edward T. Schneider in 1985 and is headquartered in Mentor, OH. | Health Technology |
Imalux Corp.
Imalux Corp. Medical SpecialtiesHealth Technology Imalux, the medical device company on a mission. They're leading the world in the development of Optical Coherence Tomography (OCT), a breakthrough medical imaging modality used to visualize tissue microstructure in real-time, at the site of patient care. With the Niris Imaging System, its first generation OCT solution, Imalux provides physicians and surgeons a valuable tissue-profiling tool to assist in the diagnosis, treatment, and surveillance of disease. Currently, clinicians do not have effective imaging methods for detecting tissue structure abnormalities in a timely manner and at the point-of-care. Physicians, therefore, must rely on prior imaging studies and visual findings to guide surgery and treatment. There exists an unmet need for real-time, high spatial resolution medical imaging that can be used in a wide range of applications and practice settings at a reasonable cost. Globally, the healthcare community is searching for ways to streamline the delivery of care without compromising clinical outcomes. The Imalux Niris Imaging System offers clinicians the ability to 'see and treat' in a single patient visit a single episode of care. Imalux is developing products and services to address this serious clinical need that cannot be satisfied by current technologies. In time, Imalux anticipates that Optical Coherence Tomography will take its place alongside x-ray, ultrasound, Magnetic Resonance Imaging (MRI), Computerized Axial Tomography (CT scans), and nuclear medicine as the 'sixth imaging modality.' At present, research efforts continue as Imalux conducts further studies to establish the value of OCT in clinical settings and lead to eventual commercialization of the technology. | Health Technology |
Anpath Group, Inc.
Anpath Group, Inc. Financial ConglomeratesFinance Anpath Group, Inc. is a holding company, through its wholly-owned subsidiary EnviroSystems, Inc., produces disinfecting, biocidal, sanitizing, and cleaning products designed to help prevent the spread of infectious microorganisms and control the growth of these disease-causing microbes, while minimizing the harmful effects to people, animals, surfaces and the environment. The company was founded on August 26, 2004 and is headquartered in Austin, TX. | Finance |
Envirosystems, Inc. /Old/ | Consumer Non-Durables |
Catheter Research, Inc.
Catheter Research, Inc. Medical SpecialtiesHealth Technology Catheter Research, Inc. manufactures interventional catheters, tube sets and other assemblies for medical devices. The company was founded on September 16, 1987 and is headquartered in Indianapolis, IN. | Health Technology |
Kivalo, Inc. |